Skip to main content

and
  1. Article

    Open Access

    Novel inhalation therapy in pulmonary fibrosis: principles, applications and prospects

    Pulmonary fibrosis (PF) threatens millions of people worldwide with its irreversible progression. Although the underlying pathogenesis of PF is not fully understood, there is evidence to suggest that the disea...

    Meiling Zheng, Wei Zhu, Fei Gao, Yu Zhuo, Mo Zheng in Journal of Nanobiotechnology (2024)

  2. Article

    Open Access

    Traditional Chinese medicine inspired dual-drugs loaded inhalable nano-therapeutics alleviated idiopathic pulmonary fibrosis by targeting early inflammation and late fibrosis

    Idiopathic pulmonary fibrosis (IPF) is a highly debilitating and fatal chronic lung disease that is difficult to cure clinically. IPF is characterized by a gradual decline in lung function, which leads to resp...

    Meiling Zheng, Kai Liu, Lei Li, Cuiling Feng, Guanghao Wu in Journal of Nanobiotechnology (2024)

  3. Article

    Open Access

    Impaired autophagy-accelerated senescence of alveolar type II epithelial cells drives pulmonary fibrosis induced by single-walled carbon nanotubes

    The rapid increase in production and application of carbon nanotubes (CNTs) has led to wide public concerns in their potential risks to human health. Single-walled CNTs (SWCNTs), as an extensively applied type...

    **ang Zhang, **nxin Hu, Yuqing Zhang, Bin Liu, Haihong Pan in Journal of Nanobiotechnology (2023)

  4. Article

    Open Access

    NAMPT encapsulated by extracellular vesicles from young adipose-derived mesenchymal stem cells treated tendinopathy in a “One-Stone-Two-Birds” manner

    Tendinopathy is the leading sports-related injury and will cause severe weakness and tenderness. Effective therapy for tendinopathy remains limited, and extracellular vesicles (EVs) derived from adipose tissue...

    Guanghao Wu, Qihang Su, Jie Li, Chao Xue, Jie Zhu in Journal of Nanobiotechnology (2023)